Company intelligence / Profile preview

SubjectWell

Austin, Texas, United Statessubjectwell.com ↗

Ownership: Private
Employees: ~230
Development stage: Commercial

Overview

SubjectWell operates the largest global patient engagement and recruitment network for clinical trials. It has completed over 1,400 studies across more than 8,800 sites in 102 countries. The company’s technology-driven approach accelerates enrollment by up to 30%, supports over 600 therapeutic areas—including rare diseases and oncology—and partners with most of the top pharmaceutical companies worldwide. Its performance-based model ensures clients only pay for patients who randomize into trials.

Therapeutic areas: OncologyInfectious DiseasesRare DiseasesOther
Industry: Contract Research Organization

Partnerships

Partners with at least sixteen of the top twenty pharmaceutical companies globally as well as major CROs and brand marketers.

Beyond the preview

Go deeper on SubjectWell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SubjectWell.

Explore the full profile